Fredun Pharmaceuticals delivers strong FY26 performance with 40% revenue growth and 72% EBITDA surge 25/05/2026 / Financial Results / Annual Financial Results Fredun Pharmaceuticals delivers strong FY26 performance with 40% revenue growth and 72% EBITDA surge Read Post ยป
